New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications
- PMID: 33761203
- PMCID: PMC8008749
- DOI: 10.1056/NEJMc2100362
New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications
References
-
- Pango lineages. Global report investigating novel coronavirus haplotypes. 2021. (https://cov-lineages.org/global_report.html).
-
- Pearson CAB, Russell TW, Davies N, et al. Estimates of severity and transmissibility of novel SARS-CoV-2 variant 501Y.V2 in South Africa. London: CMMID Repository, 2021. (https://cmmid.github.io/topics/covid19/sa-novel-variant.html).
-
- Davies N, Abbott S, Barnard RC, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. London: CMMID Repository, 2020. (https://cmmid.github.io/topics/covid19/uk-novel-variant.html). - PMC - PubMed
-
- Horby P, Huntley C, Davies N, et al. NERVTAG paper on COVID-19 variant of concern B.1.1.7. London: Department of Health and Social Care, Scientific Advisory Group for Emergencies, January 2021. (https://www.gov.uk/government/publications/nervtag-paper-on-covid-19-var...).
-
- Wibmer CK, Ayres F, Hermanus T, et al. SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. January 19, 2021. (https://www.biorxiv.org/content/10.1101/2021.01.18.427166v1). preprint. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous